DHEA and frontal fibrosing alopecia: molecular and physiopathological mechanisms
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Anais brasileiros de dermatologia (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962016000600776 |
Resumo: | Abstract The transforming growth factor-beta 1 (TGFβ1) promotes fibrosis, differentiating epithelial cells and quiescent fibroblasts into myofibroblasts and increasing expression of extracellular matrix. Recent investigations have shown that PPAR (peroxisome proliferator-activated receptor*) is a negative regulator of fibrotic events induced by TGFβ1. Dehydroepiandrosterone (DHEA) is an immunomodulatory hormone essential for PPAR functions, and is reduced in some processes characterized by fibrosis. Although scarring alopecia characteristically develops in the female biological period in which occurs decreased production of DHEA, there are no data in the literature relating its reduction to fibrogenic process of this condition. This article aims to review the fibrogenic activity of TGFβ1, its control by PPAR and its relation with DHEA in the frontal fibrosing alopecia. |
id |
SBD-1_097de472f833f15369ec54c9a7776ed7 |
---|---|
oai_identifier_str |
oai:scielo:S0365-05962016000600776 |
network_acronym_str |
SBD-1 |
network_name_str |
Anais brasileiros de dermatologia (Online) |
repository_id_str |
|
spelling |
DHEA and frontal fibrosing alopecia: molecular and physiopathological mechanismsDHEAFFAFrontal fibrosing alopeciaAlopeciaDehydroepiandrosteronePPAR gammaTransforming growth factor alphaAbstract The transforming growth factor-beta 1 (TGFβ1) promotes fibrosis, differentiating epithelial cells and quiescent fibroblasts into myofibroblasts and increasing expression of extracellular matrix. Recent investigations have shown that PPAR (peroxisome proliferator-activated receptor*) is a negative regulator of fibrotic events induced by TGFβ1. Dehydroepiandrosterone (DHEA) is an immunomodulatory hormone essential for PPAR functions, and is reduced in some processes characterized by fibrosis. Although scarring alopecia characteristically develops in the female biological period in which occurs decreased production of DHEA, there are no data in the literature relating its reduction to fibrogenic process of this condition. This article aims to review the fibrogenic activity of TGFβ1, its control by PPAR and its relation with DHEA in the frontal fibrosing alopecia.Sociedade Brasileira de Dermatologia2016-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962016000600776Anais Brasileiros de Dermatologia v.91 n.6 2016reponame:Anais brasileiros de dermatologia (Online)instname:Sociedade Brasileira de Dermatologia (SBD)instacron:SBD10.1590/abd1806-4841.20165029info:eu-repo/semantics/openAccessGaspar,Neide Kalileng2017-01-06T00:00:00Zoai:scielo:S0365-05962016000600776Revistahttp://www.anaisdedermatologia.org.br/https://old.scielo.br/oai/scielo-oai.phpabd@sbd.org.br||revista@sbd.org.br1806-48410365-0596opendoar:2017-01-06T00:00Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)false |
dc.title.none.fl_str_mv |
DHEA and frontal fibrosing alopecia: molecular and physiopathological mechanisms |
title |
DHEA and frontal fibrosing alopecia: molecular and physiopathological mechanisms |
spellingShingle |
DHEA and frontal fibrosing alopecia: molecular and physiopathological mechanisms Gaspar,Neide Kalil DHEA FFA Frontal fibrosing alopecia Alopecia Dehydroepiandrosterone PPAR gamma Transforming growth factor alpha |
title_short |
DHEA and frontal fibrosing alopecia: molecular and physiopathological mechanisms |
title_full |
DHEA and frontal fibrosing alopecia: molecular and physiopathological mechanisms |
title_fullStr |
DHEA and frontal fibrosing alopecia: molecular and physiopathological mechanisms |
title_full_unstemmed |
DHEA and frontal fibrosing alopecia: molecular and physiopathological mechanisms |
title_sort |
DHEA and frontal fibrosing alopecia: molecular and physiopathological mechanisms |
author |
Gaspar,Neide Kalil |
author_facet |
Gaspar,Neide Kalil |
author_role |
author |
dc.contributor.author.fl_str_mv |
Gaspar,Neide Kalil |
dc.subject.por.fl_str_mv |
DHEA FFA Frontal fibrosing alopecia Alopecia Dehydroepiandrosterone PPAR gamma Transforming growth factor alpha |
topic |
DHEA FFA Frontal fibrosing alopecia Alopecia Dehydroepiandrosterone PPAR gamma Transforming growth factor alpha |
description |
Abstract The transforming growth factor-beta 1 (TGFβ1) promotes fibrosis, differentiating epithelial cells and quiescent fibroblasts into myofibroblasts and increasing expression of extracellular matrix. Recent investigations have shown that PPAR (peroxisome proliferator-activated receptor*) is a negative regulator of fibrotic events induced by TGFβ1. Dehydroepiandrosterone (DHEA) is an immunomodulatory hormone essential for PPAR functions, and is reduced in some processes characterized by fibrosis. Although scarring alopecia characteristically develops in the female biological period in which occurs decreased production of DHEA, there are no data in the literature relating its reduction to fibrogenic process of this condition. This article aims to review the fibrogenic activity of TGFβ1, its control by PPAR and its relation with DHEA in the frontal fibrosing alopecia. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-12-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962016000600776 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962016000600776 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/abd1806-4841.20165029 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Dermatologia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Dermatologia |
dc.source.none.fl_str_mv |
Anais Brasileiros de Dermatologia v.91 n.6 2016 reponame:Anais brasileiros de dermatologia (Online) instname:Sociedade Brasileira de Dermatologia (SBD) instacron:SBD |
instname_str |
Sociedade Brasileira de Dermatologia (SBD) |
instacron_str |
SBD |
institution |
SBD |
reponame_str |
Anais brasileiros de dermatologia (Online) |
collection |
Anais brasileiros de dermatologia (Online) |
repository.name.fl_str_mv |
Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD) |
repository.mail.fl_str_mv |
abd@sbd.org.br||revista@sbd.org.br |
_version_ |
1752126421418901504 |